Status™ COVID-19/Flu A&B Case of 25.
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens.
- COVID-19
- Anterior nasal swab specimen − Sensitivity 93.8 %, Specificity 100%
- Nasopharyngeal − Sensitivity 93.1 %, Specificity 100%
- Flu A - Sensitivity 91.4%, Specificity 95.7%
- Flu B - Sensitivity 87.6%, Specificity 95.9%
- FDA Emergency Use Authorization (EUA)
- Visually read in 15 minutes
- Flocked nasopharyngeal swab for superior specimen collection and patient comfort
Key Benefits:
-
Rapid and Accurate Diagnosis: Obtain reliable results in just 15 minutes.
-
Simultaneous Detection: Effectively identify COVID-19 and Flu A & B with a single test.
-
High Sensitivity and Specificity: Provides accurate results, reducing the risk of false negatives and false positives.
-
Patient Comfort: Flocked swabs ensure a more comfortable and efficient specimen collection experience.
The Status™ COVID-19/Flu A&B test is essential for clinics, hospitals, and urgent care centers, facilitating quick diagnosis and helping to prevent the spread of respiratory illnesses.
Why Choose the Status™ COVID-19/Flu A&B Test?
-
Reliability: With high sensitivity and specificity rates, you can trust the results.
-
Speed: Results in just 15 minutes, ideal for high-demand settings.
-
Ease of Use: Simple specimen collection and analysis process.
Ensure the health and well-being of your patients with the Status™ COVID-19/Flu A&B test, the reliable solution for rapid and accurate detection of respiratory infections.
